| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/1993 | CA2074626A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
| 01/26/1993 | CA1313155C Antibiotic compounds and their preparation |
| 01/25/1993 | CA2074420A1 Cyclohexane and tetrahydropyran derivatives |
| 01/25/1993 | CA2073913A1 Preparation of fatty acid medicaments |
| 01/24/1993 | CA2074216A1 Topical anti-fungal agents having anti-inflammatory activity |
| 01/24/1993 | CA2070495A1 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/21/1993 | WO1993001195A1 DIBENZ[b,e]AZEPINE DERIVATIVES AND DRUGS CONTAINING THEM |
| 01/21/1993 | WO1993001181A1 Substituted indoles as anti-aids pharmaceuticals |
| 01/21/1993 | WO1993000910A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | WO1993000905A1 Tropical composition containing penciclovir |
| 01/21/1993 | WO1993000813A1 Germicidal compositions containing iodated compounds |
| 01/21/1993 | WO1992019212A3 Glycine anhydride dimethylol as a biocide and preservative |
| 01/21/1993 | DE4223438A1 Cyclische oligonucleotidphosphorthioate Cyclic oligonucleotidphosphorthioate |
| 01/21/1993 | CA2112803A1 Antiviral liponucleosides: treatment of hepatitis b |
| 01/21/1993 | CA2111710A1 Dibenz[b,e]azepin derivatives and medicaments containing these |
| 01/20/1993 | EP0523976A2 Manipulation of gene copy number in bordetella |
| 01/20/1993 | EP0523803A1 1,2,4-Oxadiazolyl-phenoxy-alkylisoxazoles and their use as antiviral agents |
| 01/20/1993 | EP0523675A1 Inhibitory agent against HIV superinfection |
| 01/20/1993 | EP0523512A1 8-vinyl- and 8-ethinyl-quinolone carboxylic acids |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | EP0523189A1 Cationic lipids for intracellular delivery of biologically active molecules |
| 01/20/1993 | EP0523160A1 Carbo-nucleoside derivatives |
| 01/20/1993 | EP0523140A1 Reagents and methods for modulating gene expression through rna mimicry |
| 01/20/1993 | EP0523110A1 Nucleoside derivatives |
| 01/20/1993 | EP0523056A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 01/20/1993 | CN1068115A 7-isoindolinyl-quinolone-and-naphthyridone carboxylic acid herivatives |
| 01/20/1993 | CN1068114A 7-azaisoindolinyl-quinolone-and-naphthyridonecarboxylic acid derivatives |
| 01/20/1993 | CN1068112A Compounds with renin-inhibiting properties, process for the preparation thereof and use thereof |
| 01/20/1993 | CN1068035A Abrogation of uiral resistance to nucleoside analogues by double-stranded rnas |
| 01/20/1993 | CA2073993A1 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids |
| 01/19/1993 | US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa |
| 01/19/1993 | US5180675 Recombinant fowlpox virus |
| 01/19/1993 | CA1312860C Process for preparation of aloe products |
| 01/19/1993 | CA1312858C 3-deoxy mycaminosyl tylonolide derivatives |
| 01/19/1993 | CA1312823C Anti viral composition |
| 01/13/1993 | EP0522560A2 Method and composition for the prevention of Lyme disease |
| 01/13/1993 | EP0522291A1 Process for purifying hepatitis a virus (HAV), virus thus purified and vaccine compositions containing it |
| 01/13/1993 | EP0522277A1 Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride |
| 01/13/1993 | EP0522084A1 Antiviral compositions and method for their use |
| 01/13/1993 | EP0522081A1 Inhibition of disease associated with immunodeficiency virus infection |
| 01/13/1993 | EP0521974A1 Veterinary treatment. |
| 01/13/1993 | EP0521906A1 Therapeutic composition containing a phenol compound and propolis useful against lipidic capside viruses, especially the herpes viruses |
| 01/13/1993 | EP0521887A1 Cephalosporins, process for their preparation and pharmaceutical compositions containing them |
| 01/13/1993 | CN1067921A Antibiotic compound |
| 01/12/1993 | US5179104 Multistage process for forming viricides |
| 01/12/1993 | US5179096 Therapeutic application of flouroquinolone derivatives |
| 01/12/1993 | US5179088 Administering bactericides |
| 01/12/1993 | US5178875 Phosphatides with tert-butanol, clarification of water, mixing with solvent then removal |
| 01/12/1993 | CA1312599C 2',3'dideoxy-2',2'difluoronucleosides |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/10/1993 | WO1993000907A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/10/1993 | CA2091264A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000362A1 New peptides (didemnins), their preparation and their use |
| 01/07/1993 | WO1993000344A1 Carbapenem derivative |
| 01/07/1993 | WO1993000114A1 Topical composition enhancing healing of herpes lesions |
| 01/07/1993 | WO1993000112A1 Attenuated revertant serotype 1 marek's disease vaccine |
| 01/07/1993 | WO1993000084A1 Methods and compositions for treating malaria and other diseases |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1992017173A3 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
| 01/07/1993 | EP0521827A1 Pharmacological active hydrazin derivatives and process for their preparation |
| 01/07/1993 | EP0521524A1 Aminooxypyrrolidinylthiocarbapenem compounds |
| 01/07/1993 | EP0521463A2 Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | EP0521240A2 Novel bacteriocin from lactococcus lactis subspecies lactis |
| 01/07/1993 | EP0521203A1 Improved process for recovering organic vapors from air |
| 01/07/1993 | EP0506830A4 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV |
| 01/07/1993 | DE4122240A1 Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel Dibenz (b, e) and azepine derivatives containing the same drug |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2111837A1 Topical composition enhancing healing of herpes lesions |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/06/1993 | CN1067654A Processes for diastereoselective synthesis of nucleosides |
| 01/06/1993 | CN1067580A Megestrol acetate formulation |
| 01/05/1993 | WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
| 01/05/1993 | US5177083 Drugs effective against retroviruses |
| 01/05/1993 | US5177067 Substituted aminoalkyl biphenyl compounds and method of treating fungal infections |
| 01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
| 01/05/1993 | US5176911 Topical compositions for use in gynecology and urology |
| 01/05/1993 | CA2089576A1 Hcv peptide antigens and methods for the determination of hcv |
| 01/05/1993 | CA2073111A1 Cycloalkyltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents |
| 01/03/1993 | WO1993001166A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 01/03/1993 | CA2109326A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 12/30/1992 | EP0520880A1 Cephalosporines having a 2-thia cephem ring, process for their preparation, pharmaceutical compositions containing them, their application as medicaments and intermediates |
| 12/30/1992 | EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14 |
| 12/30/1992 | EP0520753A1 Recombinant fowlpox vaccine for protection against Marek's disease |
| 12/30/1992 | EP0520553A1 2-Heteroarylphenyl-carbapenem antibacterial agents |
| 12/30/1992 | EP0520277A2 7-Azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives |
| 12/30/1992 | EP0520240A1 7-Isoindolinyl-quinolone and naphthyridonecarboxylic acid derivatives |
| 12/30/1992 | EP0519986A1 Synthetic polypeptides |
| 12/30/1992 | EP0395672B1 Antiviral application of alpha oligonucleotides |